Literature DB >> 15829134

Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis.

K D Ramaiah1, K N Vijay Kumar, R Ravi, P K Das.   

Abstract

The main strategy now adopted for the elimination of lymphatic filariasis (LF) is based on mass drug administrations (MDA). Annual administration of antifilarial drugs to 65%-80% of the population at risk of the disease is believed to be necessary if LF is to be eliminated, at least as a public-health problem, within a reasonable time-frame. To facilitate the development of drug-delivery strategies that are sufficient to ensure such high treatment coverages in large urban areas, a situation analysis was undertaken in the Indian city of Chennai. The subjects interviewed came from households with high, moderate, low or very low incomes. A lack of information on the prevalence and socio-economic impact of the disease meant that LF was not viewed as a major pubic-health problem in the study area, even though cases of elephantiasis and hydrocele were detected in 2%-8% and 7%-20% of the households investigated. Overall, 40% of the interviewees from very-low-income households and 78% of those from middle-income households knew that (the parasite causing) elephantiasis was transmitted by mosquitoes. Only 4% of the subjects from high-income areas and 1% of those from low-income areas were aware that filarial infection was a major cause of hydrocele. Most of the subjects (>55% of each of the four socio- economic groups considered) felt that they were not at risk of developing elephantiasis. When specifically asked, only 35% of the subjects from high-income households but 84% of those from low-income households said that they would be willing to consume tablets of an antifilarial drug (diethylcarbamazine) in MDA to eliminate LF. It is therefore unclear whether high-income households in urban areas should be included in MDA programmes. The interviewees felt that an intensive campaign of information, education, communication and advocacy would be necessary if an effective MDA-based programme were to be implemented. Drug distribution through the health services was the most preferred option.Clearly, factors such as a lack of appreciation of the socio-economic impact of LF, a general belief that the risk of elephantiasis is low, doubts about the need to include all sectors of the eligible population in MDA, and a common dependence on private practitioners make successful MDA against LF in urban areas a challenging task. On the positive side, however, an urban population is often covered by a huge network of colleges, private practitioners, non-governmental organizations and residents' associations, and such networks provide new opportunities in the development of effective drug-delivery strategies.

Entities:  

Mesh:

Year:  2005        PMID: 15829134     DOI: 10.1179/136485905X29701

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  14 in total

1.  Possible relationship among socio-economic determinants, knowledge and practices on lymphatic filariasis and implication for disease elimination in India.

Authors:  Perumal Vanamail; Subbaiah Gunasekaran
Journal:  Int J Public Health       Date:  2010-06-15       Impact factor: 3.380

2.  Awareness of health personnel about lymphatic filariasis and mass drug administration in Karnataka state of South India.

Authors:  N Joseph; Sh Subba; A Jain; B Unnikrishnan; K Nagaraj; Sm Kotian
Journal:  Australas Med J       Date:  2011-02-28

Review 3.  Lymphatic Filariasis in India : Problems, Challenges and New Initiatives.

Authors:  V K Agrawal; V K Sashindran
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Comorbidities among HIV-infected injection drug users in Chennai, India.

Authors:  S S Solomon; C S Hawcroft; P Narasimhan; R Subbaraman; A K Srikrishnan; A J Cecelia; M Suresh Kumar; Suniti Solomon; J E Gallant; D D Celentano
Journal:  Indian J Med Res       Date:  2008-05       Impact factor: 2.375

Review 5.  Urban lymphatic filariasis.

Authors:  Paul E Simonsen; Mbutolwe E Mwakitalu
Journal:  Parasitol Res       Date:  2012-12-13       Impact factor: 2.289

6.  High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone.

Authors:  Mary H Hodges; Samuel J Smith; Daniel Fussum; Joseph B Koroma; Abdul Conteh; Mustapha Sonnie; Santigie Sesay; Yaobi Zhang
Journal:  Parasit Vectors       Date:  2010-12-16       Impact factor: 3.876

Review 7.  Induction of immunoglobulin G4 in human filariasis: an indicator of immunoregulation.

Authors:  T Adjobimey; A Hoerauf
Journal:  Ann Trop Med Parasitol       Date:  2010-09

8.  Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.

Authors:  David G Addiss; Molly A Brady
Journal:  Filaria J       Date:  2007-02-15

9.  An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of gujarat.

Authors:  Pradeep Kumar; Pb Prajapati; Deepak Saxena; Abhay B Kavishwar; George Kurian
Journal:  Indian J Community Med       Date:  2008-01

Review 10.  Population migration: implications for lymphatic filariasis elimination programmes.

Authors:  K D Ramaiah
Journal:  PLoS Negl Trop Dis       Date:  2013-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.